HomepageBCRX • NASDAQ
add
BioCryst Pharmaceuticals
Vorige slotkoers
$ 6,67
Dag-range
$ 6,60 - $ 6,73
Jaar-range
$ 6,00 - $ 11,31
Beurswaarde
1,40 mld. USD
Gem. volume
4,18 mln.
Koers/winst
-
Dividendrendement
-
Primaire beurs
NASDAQ
In het nieuws
Over
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China. Wikipedia
Opgericht
1986
Hoofdvestiging
Website
Werknemers
580